ConductScience.org, home

Paper33256166

Design, Synthesis and Evaluation of New Bioactive Oxadiazole Derivatives as Anticancer Agents Targeting Bcl-2.

Hamdy R and 6 others. Int J Mol Sci, 2020. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. Design, Synthesis and Evaluation of New Bioactive Oxadiazole Derivatives as Anticancer Agents Targeting Bcl-2. Papers, record 33256166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33256166

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Design, Synthesis and Evaluation of New Bioactive Oxadiazole Derivatives as Anticancer Agents Targeting Bcl-2.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2020
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
0.53
iCite
Revised in PubMed
2021-03-04
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hamdy RRania
2Elseginy SASamia Ahttps://orcid.org/0000-0002-0040-0288
3Ziedan NINoha I
4El-Sadek MMohamedhttps://orcid.org/0000-0002-6038-1496
5Lashin EElsaid
6Jones ATArwyn Thttps://orcid.org/0000-0003-2781-8905
7Westwell ADAndrew Dhttps://orcid.org/0000-0002-5166-9236

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Drug DesignMajor topic
OxadiazolesMajor topic
Proto-Oncogene Proteins c-bcl-2Major topic
Binding Sites
Cell Line, Tumor
Cell Proliferation
Humans
Inhibitory Concentration 50
Models, Molecular
Protein Binding

Source PubMed

Download CSV of topics

References14

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128067996Virtual screening, SAR, and discovery of 5-(indole-3-yl)-2-[(2-nitrophenyl)amino] [1,3,4]-oxadiazole as a novel Bcl-2 inhibitor.Chem Biol Drug Des2017https://conductscience.org/library/papers/28067996PubMed
221934653Co-operative membrane disruption between cell-penetrating peptide and cargo: implications for the therapeutic use of the Bcl-2 converter peptide D-NuBCP-9-r8.Mol Ther2011https://conductscience.org/library/papers/21934653PubMed
39703946Expression of Bcl-2 increases intracellular glutathione by inhibiting methionine-dependent GSH efflux.Biochem Biophys Res Commun1998https://conductscience.org/library/papers/9703946PubMed
419075767Medicinal chemistry and the molecular operating environment (MOE): application of QSAR and molecular docking to drug discovery.Curr Top Med Chem2008https://conductscience.org/library/papers/19075767PubMed
528087272Synthesis and evaluation of 5-(1H-indol-3-yl)-N-aryl-1,3,4-oxadiazol-2-amines as Bcl-2 inhibitory anticancer agents.Bioorg Med Chem Lett2017https://conductscience.org/library/papers/28087272PubMed
621595920Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells.J Transl Med2011https://conductscience.org/library/papers/21595920PubMed
730012635The rise of apoptosis: targeting apoptosis in hematologic malignancies.Blood2018https://conductscience.org/library/papers/30012635PubMed
818353193Protein-protein interactions as targets for small-molecule therapeutics in cancer.Expert Rev Mol Med2008https://conductscience.org/library/papers/18353193PubMed
919088047A phase I study of the pan bcl-2 family inhibitor obatoclax mesylate in patients with advanced hematologic malignancies.Clin Cancer Res2008https://conductscience.org/library/papers/19088047PubMed
1023474389Synthesis and evaluation of 3-(benzylthio)-5-(1H-indol-3-yl)-1,2,4-triazol-4-amines as Bcl-2 inhibitory anticancer agents.Bioorg Med Chem Lett2013https://conductscience.org/library/papers/23474389PubMed
1118645028Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa.Mol Cancer Ther2008https://conductscience.org/library/papers/18645028PubMed
1230986908New Quinoline-Based Heterocycles as Anticancer Agents Targeting Bcl-2.Molecules2019https://conductscience.org/library/papers/30986908PubMed
1328209992From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors.Nat Rev Drug Discov2017https://conductscience.org/library/papers/28209992PubMed
1419238538Small inhibitor of Bcl-2, HA14-1, selectively enhanced the apoptotic effect of cisplatin by modulating Bcl-2 family members in MDA-MB-231 breast cancer cells.Breast Cancer Res Treat2010https://conductscience.org/library/papers/19238538PubMed

Download CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
40649366Hydrazides as Powerful Tools in Medicinal Chemistry: Synthesis, Reactivity, and Biological Applications.Molecules2025https://conductscience.org/library/papers/40649366PubMed
39313901Pioneering the Battle Against Breast Cancer: The Promise of New Bcl-2 Family.Anticancer Agents Med Chem2025https://conductscience.org/library/papers/39313901PubMed
37834104Design, Synthesis, and Potent Anticancer Activity of Novel Indole-Based Bcl-2 Inhibitors.Int J Mol Sci2023https://conductscience.org/library/papers/37834104PubMed
34830153New Bioactive Fused Triazolothiadiazoles as Bcl-2-Targeted Anticancer Agents.Int J Mol Sci2021https://conductscience.org/library/papers/34830153PubMed
34066442Synthesis and Anticancer Evaluation of New 1,3,4-Oxadiazole Derivatives.Pharmaceuticals (Basel)2021https://conductscience.org/library/papers/34066442PubMed
33924410Editorial for Special Issue "Bioactive Oxadiazoles".Int J Mol Sci2021https://conductscience.org/library/papers/33924410PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BCL2596PubTator's text mininghttps://conductscience.org/library/genes/596NCBI Gene
BCL2L1110018PubTator's text mininghttps://conductscience.org/library/genes/10018NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33256166

GET https://conductscience.org/api/papers/v1/33256166/authors